Repurposing compounds for Tuberculosis drug discovery

Status
Completed
Start date
End date
Start stage
Screening
End stage
Screening
Disease
Tuberculosis
Research areas
Drug

Assuming that there is an urgent need for new drugs to treat tuberculosis, GSK provided Dr. Parish with a targeted set of protease inhibitors to perform a phenotypic screen against M. tuberculosis. No inhibitors were identified.

Requires follow up.